In endometrial cancer, patients with carcinosarcoma, serous adenocarcinoma and leiomyosarcoma showed many alterations of cancer driver genes, such as MYC and CCNE1 (Table 2, Fig. 2). This evidence concerns the gene MYC and serous adenocarcinoma.